Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1970 2
1971 4
1972 2
1973 2
1974 1
1976 2
1978 2
1979 1
1980 1
1982 2
1985 2
1986 1
1987 1
1988 4
1989 7
1990 8
1991 10
1992 7
1993 6
1994 7
1995 7
1996 10
1997 11
1998 12
1999 12
2000 10
2001 12
2002 14
2003 23
2004 7
2005 19
2006 17
2007 15
2008 29
2009 32
2010 36
2011 49
2012 72
2013 59
2014 48
2015 36
2016 46
2017 47
2018 56
2019 29
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

673 results
Results by year
Filters applied: . Clear all
Page 1
Scleroderma epidemiology.
Mayes MD. Mayes MD. Rheum Dis Clin North Am. 1996 Nov;22(4):751-64. doi: 10.1016/s0889-857x(05)70299-4. Rheum Dis Clin North Am. 1996. PMID: 8923594 Review.
Determinants of mortality in systemic sclerosis: a focused review.
Poudel DR, Jayakumar D, Danve A, Sehra ST, Derk CT. Poudel DR, et al. Rheumatol Int. 2018 Oct;38(10):1847-1858. doi: 10.1007/s00296-017-3826-y. Epub 2017 Nov 7. Rheumatol Int. 2018. PMID: 29116439 Review.
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis.
Sobanski V, Giovannelli J, Allanore Y, Riemekasten G, AirĂ² P, Vettori S, Cozzi F, Distler O, Matucci-Cerinic M, Denton C, Launay D, Hachulla E; EUSTAR Collaborators. Sobanski V, et al. Arthritis Rheumatol. 2019 Sep;71(9):1553-1570. doi: 10.1002/art.40906. Epub 2019 Aug 12. Arthritis Rheumatol. 2019. PMID: 30969034 Free PMC article.
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis.
Becker M, Graf N, Sauter R, Allanore Y, Curram J, Denton CP, Khanna D, Matucci-Cerinic M, de Oliveira Pena J, Pope JE, Distler O; EUSTAR Collaborators; EUSTAR Collaborators (numerical order of centres). Becker M, et al. Ann Rheum Dis. 2019 Sep;78(9):1242-1248. doi: 10.1136/annrheumdis-2019-215145. Epub 2019 Jun 21. Ann Rheum Dis. 2019. PMID: 31227488 Free PMC article. Clinical Trial.
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort.
Wu W, Jordan S, Graf N, de Oliveira Pena J, Curram J, Allanore Y, Matucci-Cerinic M, Pope JE, Denton CP, Khanna D, Distler O; EUSTAR Collaborators. Wu W, et al. Ann Rheum Dis. 2019 May;78(5):648-656. doi: 10.1136/annrheumdis-2018-213455. Epub 2019 Mar 9. Ann Rheum Dis. 2019. PMID: 30852552 Free PMC article.
Epidemiology of systemic sclerosis.
Medsger TA Jr. Medsger TA Jr. Clin Dermatol. 1994 Apr-Jun;12(2):207-16. doi: 10.1016/s0738-081x(94)90323-9. Clin Dermatol. 1994. PMID: 8076257 Review.
673 results
Jump to page
Feedback